cycloastragenol has been researched along with paclitaxel in 1 studies
Studies (cycloastragenol) | Trials (cycloastragenol) | Recent Studies (post-2010) (cycloastragenol) | Studies (paclitaxel) | Trials (paclitaxel) | Recent Studies (post-2010) (paclitaxel) |
---|---|---|---|---|---|
62 | 0 | 55 | 31,874 | 5,729 | 15,395 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, KS; Alharbi, SA; Chinnathambi, A; Hwang, ST; Kim, C; Lee, JH; Sethi, G; Shair, OHM | 1 |
1 other study(ies) available for cycloastragenol and paclitaxel
Article | Year |
---|---|
Cycloastragenol can negate constitutive STAT3 activation and promote paclitaxel-induced apoptosis in human gastric cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 1; Janus Kinase 2; Paclitaxel; Phosphorylation; Phytotherapy; Sapogenins; Signal Transduction; STAT3 Transcription Factor; Stomach Neoplasms | 2019 |